Nevro Operating Income 2013-2024 | NVRO
Nevro Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-99 |
2022 | $6 |
2021 | $-111 |
2020 | $-63 |
2019 | $-96 |
2018 | $-42 |
2017 | $-30 |
2016 | $-23 |
2015 | $-62 |
2014 | $-28 |
2013 | $-25 |
2012 | $-19 |
Nevro Quarterly Operating Income (Millions of US $) |
|
---|---|
2024-09-30 | $-14 |
2024-06-30 | $-25 |
2024-03-31 | $-36 |
2023-12-31 | $-12 |
2023-09-30 | $-26 |
2023-06-30 | $-26 |
2023-03-31 | $-36 |
2022-12-31 | $-19 |
2022-09-30 | $82 |
2022-06-30 | $-24 |
2022-03-31 | $-33 |
2021-12-31 | $-26 |
2021-09-30 | $-46 |
2021-06-30 | $-16 |
2021-03-31 | $-23 |
2020-12-31 | $-1 |
2020-09-30 | $-4 |
2020-06-30 | $-35 |
2020-03-31 | $-23 |
2019-12-31 | $-12 |
2019-09-30 | $-16 |
2019-06-30 | $-27 |
2019-03-31 | $-42 |
2018-12-31 | $-9 |
2018-09-30 | $-9 |
2018-06-30 | $-8 |
2018-03-31 | $-16 |
2017-12-31 | $-2 |
2017-09-30 | $-4 |
2017-06-30 | $-10 |
2017-03-31 | $-13 |
2016-12-31 | $-6 |
2016-09-30 | $-2 |
2016-06-30 | $-6 |
2016-03-31 | $-9 |
2015-12-31 | $-13 |
2015-09-30 | $-18 |
2015-06-30 | $-19 |
2015-03-31 | $-12 |
2014-12-31 | $-7 |
2014-09-30 | $-6 |
2014-06-30 | $-7 |
2014-03-31 | $-7 |
2013-12-31 | |
2013-09-30 | $-5 |
2012-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.172B | $0.425B |
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $202.584B | 24.71 |
Intuitive Surgical (ISRG) | United States | $193.049B | 100.93 |
Alcon (ALC) | Switzerland | $43.825B | 29.32 |
Edwards Lifesciences (EW) | United States | $42.082B | 26.72 |
IQVIA Holdings (IQV) | United States | $36.452B | 20.08 |
IDEXX Laboratories (IDXX) | United States | $34.535B | 40.67 |
DexCom (DXCM) | United States | $30.463B | 45.88 |
Waters (WAT) | United States | $22.843B | 33.78 |
STERIS (STE) | Ireland | $21.623B | 24.89 |
SONOVA HOLDING (SONVY) | Switzerland | $20.352B | 0.00 |
Hologic (HOLX) | United States | $18.042B | 19.49 |
Sysmex ADR (SSMXY) | Japan | $13.304B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.922B | 13.27 |
Globus Medical (GMED) | United States | $11.657B | 29.52 |
Penumbra (PEN) | United States | $9.369B | 91.77 |
Masimo (MASI) | United States | $9.238B | 44.70 |
Teleflex (TFX) | United States | $8.957B | 14.28 |
Glaukos (GKOS) | United States | $7.920B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $4.988B | 0.00 |
Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
Veracyte (VCYT) | United States | $3.329B | 99.88 |
Inari Medical (NARI) | United States | $3.040B | 0.00 |
TransMedics (TMDX) | United States | $2.910B | 92.25 |
LivaNova (LIVN) | United Kingdom | $2.851B | 16.46 |
Nihon Kohden (NHNKY) | Japan | $2.276B | 17.29 |
Elekta AB (EKTAY) | Sweden | $2.261B | 20.33 |
Tandem Diabetes Care (TNDM) | United States | $2.012B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
RxSight (RXST) | United States | $1.889B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.486B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.316B | 0.00 |
Artivion (AORT) | United States | $1.237B | 82.00 |
OPKO Health (OPK) | United States | $1.051B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.881B | 14.97 |
Paragon 28 (FNA) | United States | $0.863B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.746B | 0.00 |
IRadimed (IRMD) | United States | $0.683B | 36.94 |
Mesa Laboratories (MLAB) | United States | $0.636B | 15.00 |
OrthoPediatrics (KIDS) | United States | $0.629B | 0.00 |
AxoGen (AXGN) | United States | $0.612B | 0.00 |
SiBone (SIBN) | United States | $0.569B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.531B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.523B | 0.00 |
Semler Scientific (SMLR) | United States | $0.473B | 27.82 |
Tactile Systems Technology (TCMD) | United States | $0.469B | 25.38 |
Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
CVRx (CVRX) | United States | $0.372B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.341B | 0.00 |
NeuroPace (NPCE) | United States | $0.316B | 0.00 |
AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
Inogen (INGN) | United States | $0.231B | 0.00 |
Accuray (ARAY) | United States | $0.224B | 0.00 |
Sight Sciences (SGHT) | United States | $0.203B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.164B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.139B | 14.93 |
Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
908 Devices (MASS) | United States | $0.095B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
LENSAR (LNSR) | United States | $0.087B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.083B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
InspireMD (NSPR) | Israel | $0.077B | 0.00 |
Hyperfine (HYPR) | United States | $0.074B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.072B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.069B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
Envoy Medical (COCH) | United States | $0.046B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
Spectral AI (MDAI) | United States | $0.036B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.031B | 0.00 |
Precision Optics (POCI) | United States | $0.031B | 0.00 |
Neuronetics (STIM) | United States | $0.030B | 0.00 |
DarioHealth (DRIO) | United States | $0.027B | 0.00 |
NexGel (NXGL) | United States | $0.022B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Tenon Medical (TNON) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.006B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |